Supernus Sues Actavis, Watson Over Oxtellar XR Patents
Supernus Pharmaceuticals Inc. hit Actavis Inc. and Watson Laboratories Inc. with a lawsuit in New Jersey federal court on Wednesday alleging the drugmakers are infringing two patents covering Oxtellar XR by...To view the full article, register now.
Already a subscriber? Click here to view full article